Stocks analysis

Analysis for TRV

$383.89 +6.07 (+1.61%)
  • 📈 Growth — 26/30
  • 💰 Profitability — 18/20
  • 🏦 Financial Health — 15/20
  • 💵 Valuation — 12/20
  • ⚠️ Risk — 5/10
Overall Score: 76/100

Summary:


📈 Growth & Financial Trajectory

Over the 8 quarters, Revenue rose from about $11.90B in 2024 Q3 to $12.15B in 2026 Q2 (~2% growth). Net income climbed from ~$1.27B to ~$2.21B, up ~74%, signaling improving profitability despite modest top-line growth. The cadence shows steady earnings leverage with a meaningful step-up in late 2025.

💰 Margins & Cash Flow

  • Operating Margin ranged mid-teens to about 25% (peak in 2025 Q4: 25%), reflecting strong margin mix. - Cash Flow From Operating Activities (continuing) largely positive across quarters (roughly $1.9–$2.7B in several periods; 2026 Q2: $1.92B). - Net Cash Flow was modestly positive or near break-even in later quarters as investing outflows ($1.7–$3.4B) and financing moves offset operating cash.

🛡️ Balance Sheet & Liquidity

Current assets ~$143.58B vs current liabilities ~$110.46B yields a Current Ratio ~1.30x. Equity ≈ $33.12B with virtually no noncurrent liabilities evident, and total assets ~$143.58B, indicating solid liquidity and asset support for near-term obligations.

⚠️ Key Drivers & Risks

  • Drivers: underwriting profitability and premium revenue; strong investment income support.
  • Risks: catastrophe/claims volatility, sensitivity to interest rates, and concentration in short-dated liabilities could pressure liquidity if rates or claims sharpen.

📊 Key Financial Fundamentals

Valuation Multiples
Market Cap $78.84B
P/E Ratio 9.50
Forward P/E 11.83
P/S Ratio 1.61
P/B Ratio 2.08
EV / EBITDA 7.60
Profitability & Returns
Gross Margin N/A
Operating Margin 22.02%
Net Margin 16.95%
ROE 25.62%
ROIC 19.95%
Financial Health & Liquidity
Current Ratio 1.00
Quick Ratio 1.00
Financial Scale & Cash Flow
Revenue $48.99B
Net Income $8.30B
FCF Yield 13.99%
Free Cash Flow $11.03B
Total Debt To Equity 0.27